SCHEMBL25643117

SCHEMBL25643117

COc1ccc(Br)c2c(C#N)c(NC(=O)OC(C)(C)C)sc12

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.38
RXFP1 Q9HBX9 1/20 0.38
KDM4E B2RXH2 4/20 0.36
MAPT P10636 3/20 0.36
HPGD P15428 3/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 2/20 0.36
GAA P10253 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
AAK1 Q2M2I8 3/20 0.34
BRAF P15056 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TGFBR1 P36897 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPK8 P45983 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24717559 0.87 ALDH1A1 (0.36) ALDH1A1KDM4EMAPTHPGDLMNA
SCHEMBL23498289 0.86 MEN1 (0.36) ALDH1A1KDM4EMAPTHPGDMEN1
SCHEMBL29812974 0.86 MEN1 (0.36) ALDH1A1KDM4EMAPTHPGDMEN1
SCHEMBL25643115 0.85 ALDH1A1 (0.47) ALDH1A1RXFP1KDM4EMAPTHPGD
SCHEMBL25643118 0.80 AAK1 (0.34) ALDH1A1RXFP1KDM4EMAPTHPGD
SCHEMBL23496898 0.79 LCK (0.39) ALDH1A1RXFP1KDM4EMAPTHPGD
SCHEMBL29813129 0.79 LCK (0.39) ALDH1A1RXFP1KDM4EMAPTHPGD
SCHEMBL25639711 0.77 ATR (0.37) ALDH1A1KDM4EMAPTLMNAMEN1
SCHEMBL31491061 0.75 EGLN2 (0.35) ALDH1A1KDM4EMAPTHPGDPOLB
SCHEMBL31085802 0.75 LCK (0.34) ALDH1A1MAPTNPC1TP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104018-A1 SUBSTITUTED BICYCLIC HETEROARYL COMPOUND AS KRAS G12D INHIBITOR 苏州浦合医药科技有限公司 2023-06-15 WO disclosed